BioDTech Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

BioDTech General Information

Description

Developer of specialty chemicals intended to accelerate the development of technologically advanced products geared towards the endotoxin market. The company's chemicals detect, neutralize and remove endotoxin associated with gram-negative bacteria and provide both quantitative and qualitative results to the end-users, thereby enabling scientists to design assays that are user-friendly and yield rapid, quantitative and specific results without expensive training or equipment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2100 SouthBridge Parkway
  • Suite 650
  • Birmingham, AL 35209
  • United States
+1 (205)
Primary Industry
Specialty Chemicals
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 2100 SouthBridge Parkway
  • Suite 650
  • Birmingham, AL 35209
  • United States
+1 (205)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioDTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 27-May-2020 Completed Generating Revenue
5. Merger/Acquisition 28-Nov-2018 Completed Generating Revenue
4. Accelerator/Incubator 01-Nov-2018 Completed Generating Revenue
3. Later Stage VC 25-Aug-2010 Completed Generating Revenue
2. Early Stage VC 01-Jul-2007 $1M $1.11M Completed Startup
1. Seed Round 13-Jan-2005 $110K $110K Completed Startup
To view BioDTech’s complete valuation and funding history, request access »

BioDTech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of specialty chemicals intended to accelerate the development of technologically advanced products geared towa
Specialty Chemicals
Birmingham, AL

Ebersberg, Germany
 

Dusseldorf, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioDTech Competitors (3)

One of BioDTech’s 3 competitors is Eurofins Genomics Europe Shared Services, a Corporation company based in Ebersberg, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eurofins Genomics Europe Shared Services Corporation Ebersberg, Germany
Numaferm Venture Capital-Backed Dusseldorf, Germany
Integrated DNA Technologies Formerly PE-Backed Coralville, IA
You’re viewing 3 of 3 competitors. Get the full list »

BioDTech Patents

BioDTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014022530-A1 The use of endotoxin neutralization as a biomarker for sepsis Inactive 31-Jul-2012
EP-2859355-A2 The use of endotoxin neutralization as a biomarker for intestinal wall damage Inactive 08-Jun-2012
EP-2859355-A4 The use of endotoxin neutralization as a biomarker for intestinal wall damage Inactive 08-Jun-2012
US-20150152470-A1 The use of endotoxin neutralization as a biomarker for intestinal wall damage Inactive 08-Jun-2012
WO-2013185029-A2 The use of endotoxin neutralization as a biomarker for intestinal wall damage Inactive 08-Jun-2012 C12Q1/37
To view BioDTech’s complete patent history, request access »

BioDTech Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Greer Capital Advisors Venture Capital Minority
Innovation Depot Accelerator/Incubator Minority
Inventa Biotech Corporation Majority
Targeted Technology Venture Capital Minority
To view BioDTech’s complete investors history, request access »

BioDTech FAQs

  • When was BioDTech founded?

    BioDTech was founded in 2003.

  • Where is BioDTech headquartered?

    BioDTech is headquartered in Birmingham, AL.

  • What industry is BioDTech in?

    BioDTech’s primary industry is Specialty Chemicals.

  • Is BioDTech a private or public company?

    BioDTech is a Private company.

  • What is BioDTech’s current revenue?

    The current revenue for BioDTech is .

  • How much funding has BioDTech raised over time?

    BioDTech has raised $1.71M.

  • Who are BioDTech’s investors?

    Greer Capital Advisors, Innovation Depot, Inventa Biotech, and Targeted Technology have invested in BioDTech.

  • Who are BioDTech’s competitors?

    Eurofins Genomics Europe Shared Services, Numaferm, and Integrated DNA Technologies are competitors of BioDTech.

  • When was BioDTech acquired?

    BioDTech was acquired on 27-May-2020.

  • Who acquired BioDTech?

    BioDTech was acquired by Axe Compute.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process